Shopping Cart
- Remove All
- Your shopping cart is currently empty
Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $478 | In Stock | |
5 mg | $1,390 | In Stock | |
10 mg | $2,280 | In Stock |
Description | Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas. |
Alias | RO7082859, RG 6026, CD20-TCB |
Molecular Weight | 170.37 kDa |
Cas No. | 2229047-91-8 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.